| Code | CSB-RA099607A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:2000 |
| IHC | 1:50-1:200 |
| IF | 1:50-1:200 |
| FC | 1:50-1:200 |
IGFBP7, also known as insulin-like growth factor-binding protein 7 or MAC25, plays a multifaceted role in cellular regulation beyond its classical function of modulating IGF signaling. This secreted protein influences cellular senescence, apoptosis, and adhesion processes, making it a compelling target in cancer biology, vascular research, and studies of metabolic disease. Its documented involvement in tumor suppression and angiogenesis has positioned IGFBP7 as a biomarker of interest across multiple disease contexts.
This recombinant rabbit monoclonal antibody, clone 5E10, offers the reproducibility and sequence-defined consistency that demanding experimental workflows require. Generated against a synthetic peptide derived from human IGFBP7, the antibody undergoes affinity chromatography purification to ensure reliable performance across experiments and extended studies.
Validation data demonstrates robust detection in Western blot applications across multiple human cell lines, including Jurkat, HeLa, HepG2, and THP-1 lysates. The observed band at approximately 34 kDa, compared to the predicted 29 kDa molecular weight, likely reflects post-translational modifications such as glycosylation, which is characteristic of this secreted protein. Immunohistochemistry validation in paraffin-embedded human endometrial carcinoma tissue confirms utility for pathological investigations, while immunofluorescence staining in HeLa cells reveals cytoplasmic localization patterns. Flow cytometry analysis using 786-O renal carcinoma cells demonstrates clear positive signal separation from isotype controls, supporting quantitative single-cell studies.
With validated performance spanning Western blot, immunohistochemistry, immunofluorescence, and flow cytometry, this antibody provides flexibility for researchers investigating IGFBP7 in oncology, senescence biology, and metabolic regulation contexts.
There are currently no reviews for this product.